1. Home
  2. LIXT vs MSGM Comparison

LIXT vs MSGM Comparison

Compare LIXT & MSGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIXT
  • MSGM
  • Stock Information
  • Founded
  • LIXT 2005
  • MSGM 2018
  • Country
  • LIXT United States
  • MSGM United States
  • Employees
  • LIXT N/A
  • MSGM 65
  • Industry
  • LIXT Biotechnology: Pharmaceutical Preparations
  • MSGM Computer Software: Prepackaged Software
  • Sector
  • LIXT Health Care
  • MSGM Technology
  • Exchange
  • LIXT Nasdaq
  • MSGM Nasdaq
  • Market Cap
  • LIXT 6.3M
  • MSGM 4.9M
  • IPO Year
  • LIXT N/A
  • MSGM 2021
  • Fundamental
  • Price
  • LIXT $1.27
  • MSGM $1.26
  • Analyst Decision
  • LIXT
  • MSGM Hold
  • Analyst Count
  • LIXT 0
  • MSGM 1
  • Target Price
  • LIXT N/A
  • MSGM $5.00
  • AVG Volume (30 Days)
  • LIXT 155.3K
  • MSGM 32.3K
  • Earning Date
  • LIXT 03-18-2025
  • MSGM 03-31-2025
  • Dividend Yield
  • LIXT N/A
  • MSGM N/A
  • EPS Growth
  • LIXT N/A
  • MSGM N/A
  • EPS
  • LIXT N/A
  • MSGM 1.84
  • Revenue
  • LIXT N/A
  • MSGM $8,460,953.00
  • Revenue This Year
  • LIXT N/A
  • MSGM $23.00
  • Revenue Next Year
  • LIXT N/A
  • MSGM $72.82
  • P/E Ratio
  • LIXT N/A
  • MSGM $0.70
  • Revenue Growth
  • LIXT N/A
  • MSGM N/A
  • 52 Week Low
  • LIXT $1.25
  • MSGM $1.01
  • 52 Week High
  • LIXT $4.40
  • MSGM $4.16
  • Technical
  • Relative Strength Index (RSI)
  • LIXT 28.82
  • MSGM 41.47
  • Support Level
  • LIXT $1.35
  • MSGM $1.25
  • Resistance Level
  • LIXT $3.00
  • MSGM $1.33
  • Average True Range (ATR)
  • LIXT 0.26
  • MSGM 0.07
  • MACD
  • LIXT -0.13
  • MSGM -0.01
  • Stochastic Oscillator
  • LIXT 1.15
  • MSGM 5.26

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

About MSGM Motorsport Games Inc.

Motorsport Games Inc is a motorsport network company that combines engaging video games with esports competitions and content for racing fans and gamers around the globe. The company has its reportable segments into the development and publishing of interactive racing video games, entertainment content and services, and the organization and facilitation of esports tournaments, competitions, and events for licensed racing games as well as on behalf of third-party video game racing series and other video game publishers. The majority of the revenue is earned from Gaming.

Share on Social Networks: